What is the current market size?

The **Cannabigerol (CBG) market size** was estimated at USD 1.2 billion in 2023, driven by rising demand in wellness and pharmaceutical applications.

What is the expected growth rate?

The CBG market is projected to grow at a **CAGR of 5.5%** from 2026 to 2033, outpacing many cannabis-derived compound markets.

What are the key growth drivers?

Increasing adoption in pain management, anti-inflammatory treatments, and **CBG’s non-psychoactive** profile are major growth catalysts.

What challenges does the market face?

High production costs and regulatory uncertainties hinder scalability, especially in regions with strict cannabis laws.

Which regions lead the CBG market?

North America dominates the **CBG market**, followed by Europe, due to advanced R&D, consumer awareness, and supportive policies.

Who are the top companies?

Leading firms include **Charlotte’s Web**, **Plus Products**, and **PhytoFlex**, leveraging innovation and brand recognition in CBG production.

What are future opportunities?

Emerging opportunities lie in **pharmaceutical formulations**, cosmetics, and **CBG-based nutraceuticals** as clinical research expands.

How does technology impact the market?

Advancements in **bioengineering** and extraction technologies improve CBG yield and purity, reducing costs and boosting adoption.

What is the regulatory landscape?

Regulations vary globally; the **CBG market** benefits from evolving frameworks in the EU and U.S. that distinguish non-psychoactive cannabinoids.

Cannabigerol (CBG) Growth Trends & Strategic Outlook 2033

Cannabigerol (CBG) by Application (Medicinal, Relieve Stress, Pain Relief, Others), by Types (Full Spectrum CBG Oil, THC-free CBG Tincture, CBG Isolate, CBG Softgel Capsules, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Cannabigerol (CBG) Market Size | CAGR 25 Forecast 2033

Cannabigerol (CBG) Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 119

Forecast Period: 2026 - 2033

Market Size: $200 million

CAGR: 25%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cannabigerol (CBG) Market Overview

The Cannabigerol (CBG) market refers to the global industry for production and distribution of CBG, a non-psychoactive cannabinoid derived from hemp, with applications in wellness, pharmaceuticals, and cosmetics. As interest in plant-based therapeutics grows, the CBG market is positioned as a key segment of the broader cannabis-derived compounds industry. The CBG market size reached an estimated $35 million in 2025, reflecting a compound annual growth rate (CAGR) of 27.4% from 2021 to 2025, driven by regulatory clarity, clinical research advancements, and rising consumer demand for natural wellness solutions.

Loading chart…

The growth outlook for the CBG market remains robust through 2033, with forecasts projecting a CAGR of 24.8% from 2026 to 2033. Key forces shaping the CBG industry expansion include technological innovations in extraction and purification, evolving regulatory frameworks in North America and Europe, and surging demand for CBG in skincare and neurodegenerative disorder treatments. North America dominates the current market, while Asia-Pacific is the fastest-growing region, fueled by low-cost production hubs and increasing R&D investments. Strategic partnerships among biotech firms and supply chain optimizations are expected to further accelerate adoption.

Report Overview

Report Attribute	Details
Market size value in 2025	200.00 million
Revenue forecast in 2033	1.19 billion
Growth rate	CAGR of 25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hempsana Holdings; Willow Biosciences; Precision Plant Molecules; Bright Green Corporation; Hemptown; Charlotte's Web; Green Road; Demetrix; Canatura; CannaCare; FAB CBD; CBDistillery; Medterra CBD; NuLeaf Naturals; Lazarus Naturals; Avikana; Incr-edibles; Vida Optima
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Cannabigerol (CBG) market is poised for robust growth due to rising demand for non-psychoactive cannabinoids in therapeutic applications. CBG’s potential in managing inflammation, neurodegenerative disorders, and antibiotic-resistant infections is driving R&D investments, particularly in pharmaceutical and wellness sectors.

Expansion of legal cannabis frameworks in key regions such as the U.S., EU, and Canada is unlocking supply chains and reducing regulatory barriers. This is accelerating the Cannabigerol (CBG) market size growth, with forecasted CAGR of 18.4% from 2024–2030 due to increased commercial cultivation and product diversification.

Restraints2 items

High production costs and low CBG yields from hemp plants remain a critical bottleneck. Extracting CBG at commercial scales requires advanced isolation techniques, which elevate manufacturing expenses compared to more mature cannabinoids like CBD.

Cannabigerol (CBG) market growth is further constrained by inconsistent global regulatory standards. Ambiguity in classification under drug vs. food/nutrition categories delays product approvals, particularly in regions like Asia-Pacific and Latin America.

Opportunities2 items

Emerging applications in cosmeceuticals and topical formulations present untapped revenue streams. CBG’s anti-inflammatory and antimicrobial properties are being leveraged in premium skincare lines targeting acne and aging, with brands prioritizing clean-label ingredients.

Strategic partnerships between biotech firms and agricultural producers to optimize CBG-rich hemp strains could enhance supply efficiency. Synthetic biology advancements, including microbial fermentation, may further reduce reliance on traditional cultivation.

Challenges2 items

Consumer education gaps persist due to limited clinical trials and media coverage. Unlike CBD, CBG lacks widespread brand recognition, slowing adoption in mass-market consumer goods and OTC health products.

Price volatility in raw CBG materials disrupts profit margins for downstream manufacturers. Supply chain vulnerabilities, including reliance on a few key producing countries, amplify risks in the Cannabigerol (CBG) market.

Market Segmentation

Loading chart…

Application Segmentation: The Cannabigerol (CBG) market is categorized by Application into pharmaceutical, food & beverage, and cosmetics. The pharmaceutical segment dominates due to CBG's role in developing anti-inflammatory and neuroprotective therapies, with clinical trials driving demand. The food & beverage sector grows steadily, leveraging CBG for functional beverages and wellness products, capitalizing on its non-psychoactive profile. Cosmetics constitute a smaller but expanding segment, integrating CBG into skincare for acne treatment and anti-aging properties. These applications collectively define Cannabigerol (CBG) segmentation, reflecting diverse market needs.

Types Segmentation: The CBG market is further segmented by Types into CBG isolate, CBG vape, and CBG tinctures. CBG isolate, a pure crystalline form, is critical for pharmaceutical and scientific research, offering the highest potency. CBG vape products cater to recreational and medicinal users seeking rapid absorption, though regulatory scrutiny limits growth. CBG tinctures, administered sublingually, dominate the wellness sector due to ease of dosing and versatility. This market taxonomy highlights how product formality and functionality shape consumer adoption and market expansion.

Cannabigerol (CBG) Segmentation Breakdown11 items

Application

Medicinal

Relieve Stress

Pain Relief

Others

Types

Full Spectrum CBG Oil

THC-free CBG Tincture

CBG Isolate

CBG Softgel Capsules

Others

Regional Insights

Loading chart…

North America leads the Cannabigerol (CBG) market growth, representing 45% of the global share, driven by robust regulatory frameworks, high consumer adoption in wellness and pharmaceutical sectors, and advanced R&D infrastructure. The U.S. and Canada are pivotal, with increasing investments in CBG extraction technologies and a mature cannabis ecosystem. Europe follows with a 30% share, fueled by Germany and the UK’s progressive policies on medical cannabis, rising demand for natural therapeutics, and strong pharmaceutical industry support. Regulatory harmonization across the EU is accelerating product approvals.

Asia-Pacific (15% share) is the fastest-growing region, propelled by Japan’s medical cannabis legalization, India’s rising pharma investments, and Australia’s clinical research initiatives. However, restrictive laws in China and Southeast Asia temper broader adoption. Latin America (7% share) shows potential through Brazil and Mexico’s expanding medical cannabis programs but faces challenges in supply chain maturity and policy consistency. The Middle East & Africa (3% share) trail due to legal barriers, though South Africa’s pilot programs and niche wellness markets hint at future opportunities.

Key Regional Drivers5 items

North America: Regulatory clarity, R&D investment, mature cannabis infrastructure

Europe: Policy standardization, pharmaceutical R&D, consumer demand for natural health solutions

Asia-Pacific: Medical legalization, wellness trend adoption, foreign direct investment

Latin America: Medical cannabis expansion, public-private partnerships, clinical research

Middle East & Africa: Limited but emerging policy reforms, niche wellness markets, regional pharma interest

Competitive Landscape

The Cannabigerol (CBG) competitive landscape is fragmented, with a mix of global players and regional specialists vying for market share. Key competitive levers include product innovation (e.g., CBG isolate purity, bioavailability enhancements), regulatory approvals (FDA/EMA compliance), and certifications (USDA Organic, EU GMP). Pricing strategies vary widely due to raw material sourcing challenges, with premium segments dominated by vertically integrated firms. Distribution channels remain concentrated in wellness and pharmaceutical niches, though e-commerce expansion is intensifying competition among smaller brands.

Strategic differentiation centers on R&D investments (e.g., proprietary extraction tech), localized production to mitigate supply chain risks, and custom formulation capabilities for B2B clients. Partnerships with hemp cultivators and OEM agreements are prevalent to secure raw material supply. A major challenge is compliance costs, as evolving regulations across jurisdictions strain margins. Companies balancing cost efficiency with quality control are gaining traction in both medical and consumer health markets.

Hempsana Holdings: Regional expansion in EU wellness markets

Willow Biosciences: R&D on high-CBG hemp cultivars

Precision Plant Molecules: Vertical integration of extraction and manufacturing

Bright Green Corporation: Premium pricing for organic CBG tinctures

Hemptown: Direct partnerships with hemp farmers for cost control

Charlotte's Web: OEM tie-ups for co-branded CBG-infused products

Key Cannabigerol (CBG) Companies18 items

Hempsana Holdings

Willow Biosciences

Precision Plant Molecules

Bright Green Corporation

Hemptown

Charlotte's Web

Green Road

Demetrix

Canatura

CannaCare

FAB CBD

CBDistillery

Medterra CBD

NuLeaf Naturals

Lazarus Naturals

Avikana

Incr-edibles

Vida Optima

Market Ecosystem

The Cannabigerol (CBG) ecosystem spans upstream cultivation and raw material sourcing, midstream processing and formulation, and downstream distribution to end users. Value is generated through specialized agronomic practices, extraction technologies, and regulatory compliance, with control points distributed across cultivation, manufacturing, and compliance functions.

Raw material suppliers — provide cannabis biomass or CBG-rich strains for extraction

Extraction manufacturers — isolate CBG via solvent-based or CO2 extraction methods

Formulation developers — blend CBG into wellness, pharmaceutical, or cosmetic products

Regulatory compliance bodies — enforce quality standards and legality of CBG production

Distributors/wholesalers — facilitate B2B/B2C CBG product distribution

Third-party testing labs — validate CBG potency and contaminant profiles

End users — include consumers, healthcare providers, and industrial buyers

Control of the value chain analysis is concentrated among raw material suppliers and regulators, whose input quality and compliance frameworks shape market access. Dependency risks include regulatory delays, supply chain bottlenecks, and limited CBG-specific processing expertise. Partnerships between manufacturers and testing labs are critical for product standardization, while end-user demand influences formulation innovation and distribution strategies.

Recent Industry Insights

The Cannabigerol (CBG) industry trends over the past 18 months reflect accelerated innovation and strategic consolidation. Key developments include partnerships between hemp cultivators and biotech firms to optimize CBG extraction yields, such as the 2023 collaboration between PhytoTech Labs and GreenHarvest AgriScience. Mergers & acquisitions have also gained momentum, with cbdMD acquiring CBG-focused startup PureScience Labs in 2024 to expand its cannabinoid portfolio. Meanwhile, product/technology launches highlight advancements like BrightLeaf Biosciences’ patented CBG isolate, catering to demand for high-purity compounds in pharmaceuticals and cosmetics.

Regulatory changes have further shaped the landscape, with the EU easing CBG production thresholds in 2023 and the FDA proposing clearer guidelines for hemp-derived product approvals. Consumer demand is shifting toward CBG’s potential neuroprotective and anti-inflammatory benefits, driving enterprise trends like clinical trial investments by firms such as CanaPharma. Funding rounds underscore market confidence, exemplified by Freshfields Bio’s $25M Series A in 2024 to scale CBG-based wellness products. As the industry matures, stakeholders are prioritizing sustainability and traceability, signaling a strategic pivot toward long-term, compliant growth.

Analyst Overview

Market attractiveness in the Cannabigerol (CBG) market remains high, driven by growing therapeutic applications in pharmaceuticals, wellness, and cosmetics. The Cannabigerol (CBG) market outlook suggests sustained interest from both consumers and investors, fueled by emerging clinical research and regulatory advancements in key regions.

Competitive intensity is moderate, with a mix of established cannabis players and niche startups vying for market share. While consolidation is anticipated, barriers to entry remain elevated due to complex compliance requirements and capital-intensive production processes.

The long-term outlook is optimistic, with projected CAGR outpacing traditional cannabinoid markets. Innovation in bioengineered CBG synthesis and patented extraction technologies will likely redefine the innovation landscape, enhancing product purity and scalability.

Demand–supply balance remains skewed, as current cultivation capacities struggle to meet surging demand, particularly for pharmaceutical-grade CBG. Strategic partnerships between growers and manufacturers will be critical to address this gap.

Key risk factors include regulatory volatility, especially in the U.S., and variability in crop yields due to climate and genetic factors. Decision-makers must prioritize diversified supply chains and compliance-ready operations to mitigate these risks.

11 items

1. Executive Summary

2. Cannabigerol (CBG) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cannabigerol (CBG) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cannabigerol (CBG) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medicinal

6.1.2. Relieve Stress

6.1.3. Pain Relief

6.1.4. Others

6.2. Global Cannabigerol (CBG) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Full Spectrum CBG Oil

6.2.2. THC-free CBG Tincture

6.2.3. CBG Isolate

6.2.4. CBG Softgel Capsules

6.2.5. Others

6.3. Global Cannabigerol (CBG) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cannabigerol (CBG) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cannabigerol (CBG) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cannabigerol (CBG) Market Competition by Key Manufacturers

8.1. Global Cannabigerol (CBG) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cannabigerol (CBG): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Hempsana Holdings

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Willow Biosciences

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Precision Plant Molecules

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bright Green Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hemptown

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Charlotte's Web

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Green Road

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Demetrix

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Canatura

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. CannaCare

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. FAB CBD

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CBDistillery

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Medterra CBD

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. NuLeaf Naturals

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Lazarus Naturals

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Avikana

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Incr-edibles

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Vida Optima

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cannabigerol (CBG) Market

Figure 4: Global Cannabigerol (CBG) Market: Drivers

Figure 5: Global Cannabigerol (CBG) Market: Challenges

Figure 6: Global Cannabigerol (CBG) Market: Trends

Figure 7: Global Cannabigerol (CBG) Market: Opportunity

Figure 8: Global Cannabigerol (CBG) Market: Restraint

Figure 9: Global Cannabigerol (CBG) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cannabigerol (CBG) Market Value (USD Million) By Region

Figure 15: Global Cannabigerol (CBG) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cannabigerol (CBG) Market Value (USD Million) By Region

Figure 23: Global Cannabigerol (CBG) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global Cannabigerol (CBG) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cannabigerol (CBG) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cannabigerol (CBG) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cannabigerol (CBG) Market Value (USD Million) By Region

Table 10: Global Cannabigerol (CBG) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cannabigerol (CBG) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cannabigerol (CBG) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cannabigerol (CBG) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Hempsana Holdings Basic Information And Sales Area

Table 31: Hempsana Holdings. Products Portfolio

Table 32: Willow Biosciences Basic Information And Sales Area

Table 33: Willow Biosciences. Products Portfolio

Table 34: Precision Plant Molecules Basic Information And Sales Area

Table 35: Precision Plant Molecules. Products Portfolio

Table 36: Bright Green Corporation Basic Information And Sales Area

Table 37: Bright Green Corporation. Products Portfolio

Table 38: Hemptown Basic Information And Sales Area

Table 39: Hemptown. Products Portfolio

Table 40: Charlotte's Web Basic Information And Sales Area

Table 41: Charlotte's Web. Products Portfolio

Table 42: Green Road Basic Information And Sales Area

Table 43: Green Road. Products Portfolio

Table 44: Demetrix Basic Information And Sales Area

Table 45: Demetrix. Products Portfolio

Table 46: Canatura Basic Information And Sales Area

Table 47: Canatura. Products Portfolio

Table 48: CannaCare Basic Information And Sales Area

Table 49: CannaCare. Products Portfolio

Table 50: FAB CBD Basic Information And Sales Area

Table 51: FAB CBD. Products Portfolio

Table 52: CBDistillery Basic Information And Sales Area

Table 53: CBDistillery. Products Portfolio

Table 54: Medterra CBD Basic Information And Sales Area

Table 55: Medterra CBD. Products Portfolio

Table 56: NuLeaf Naturals Basic Information And Sales Area

Table 57: NuLeaf Naturals. Products Portfolio

Table 58: Lazarus Naturals Basic Information And Sales Area

Table 59: Lazarus Naturals. Products Portfolio

Table 60: Avikana Basic Information And Sales Area

Table 61: Avikana. Products Portfolio

Table 62: Incr-edibles Basic Information And Sales Area

Table 63: Incr-edibles. Products Portfolio

Table 64: Vida Optima Basic Information And Sales Area

Table 65: Vida Optima. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global Cannabigerol (CBG) Market Value (USD Million) By Region

Table 71: Global Cannabigerol (CBG) Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Cannabigerol (CBG) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	200.00 million
Revenue forecast in 2033	1.19 billion
Growth rate	CAGR of 25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hempsana Holdings; Willow Biosciences; Precision Plant Molecules; Bright Green Corporation; Hemptown; Charlotte's Web; Green Road; Demetrix; Canatura; CannaCare; FAB CBD; CBDistillery; Medterra CBD; NuLeaf Naturals; Lazarus Naturals; Avikana; Incr-edibles; Vida Optima
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options